194 related articles for article (PubMed ID: 23549634)
1. Management of patients in a combined thyroid eye clinic in secondary care.
Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B
Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634
[TBL] [Abstract][Full Text] [Related]
2. Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration.
Quinn AS; Dujardin LR; Knight B; Benzimra J; Quinn AG; Vaidya B
Int Ophthalmol; 2018 Feb; 38(1):301-306. PubMed ID: 28181061
[TBL] [Abstract][Full Text] [Related]
3. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
[TBL] [Abstract][Full Text] [Related]
4. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
[TBL] [Abstract][Full Text] [Related]
5. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
Edmunds MR; Boelaert K
Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
[TBL] [Abstract][Full Text] [Related]
6. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey.
Estcourt S; Hickey J; Perros P; Dayan C; Vaidya B
Eur J Endocrinol; 2009 Sep; 161(3):483-7. PubMed ID: 19542244
[TBL] [Abstract][Full Text] [Related]
7. Thyroid eye disease in Eastern Province of Saudi Arabia: clinical profile and correlation with vitamin D deficiency.
Alali M; Alkulaib NS; Alkhars A; Albadri K; Al Hassan S; Elewa M; Aldairi W; Alsaqer SK; Al-Abdulqader RA; Alhammad F
Orbit; 2024 Feb; 43(1):28-32. PubMed ID: 36855900
[TBL] [Abstract][Full Text] [Related]
8. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
9. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
[TBL] [Abstract][Full Text] [Related]
10. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
[TBL] [Abstract][Full Text] [Related]
11. Association of Other Autoimmune Diseases With Thyroid Eye Disease.
Kelada M; Avari P; Farag S; Akishar R; Jain R; Aziz A; Feeney C; Bravis V; Meeran K; Lee V
Front Endocrinol (Lausanne); 2021; 12():644200. PubMed ID: 33746907
[TBL] [Abstract][Full Text] [Related]
12. A Multidisciplinary Thyroid Eye Clinic: A One-stop Shop.
Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Winter H; Huna-Baron R; Wygnanski-Jaffe T; Ben Simon G
Isr Med Assoc J; 2022 Oct; 24(10):671-676. PubMed ID: 36309864
[TBL] [Abstract][Full Text] [Related]
13. Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial.
Dietrich A; Taylor P; White P; Wilson V; Uddin J; Lee RWJ; Dayan C; Jackson S;
Psychol Health Med; 2018; 23(sup1):1341-1355. PubMed ID: 30092670
[TBL] [Abstract][Full Text] [Related]
14. The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease.
Iñiguez-Ariza NM; Sharma A; Garrity JA; Stan MN
Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):551-555. PubMed ID: 33782324
[TBL] [Abstract][Full Text] [Related]
15. Thyroid-associated ophthalmopathy in Iranian patients.
Kashkouli MB; Jam S; Sabzvari D; Ketabi N; Azarinia S; SeyedAlinaghi S; Mofid A
Acta Med Iran; 2011; 49(9):612-8. PubMed ID: 22052145
[TBL] [Abstract][Full Text] [Related]
16. A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom.
Lee V; Avari P; Williams B; Perros P; Dayan C;
Eye (Lond); 2020 Sep; 34(9):1662-1671. PubMed ID: 31836832
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Graves' disease in patients with thyroid eye disease].
Sviridenko NY; Sheremeta MS; Belovalova IM; Melnichenko GA
Vestn Oftalmol; 2021; 137(6):128-135. PubMed ID: 34965078
[TBL] [Abstract][Full Text] [Related]
18. Bilateral versus unilateral thyroid eye disease.
Kashkouli MB; Kaghazkanani R; Heidari I; Ketabi N; Jam S; Azarnia S; Pakdel F
Indian J Ophthalmol; 2011; 59(5):363-6. PubMed ID: 21836341
[TBL] [Abstract][Full Text] [Related]
19. Hyperthyroid vs hypothyroid eye disease: the same severity and activity.
Kashkouli MB; Pakdel F; Kiavash V; Heidari I; Heirati A; Jam S
Eye (Lond); 2011 Nov; 25(11):1442-6. PubMed ID: 21818129
[TBL] [Abstract][Full Text] [Related]
20. Ophthalmic complications in juvenile Graves' Disease - clinic and therapeutic approaches.
Krassas GE
Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():223-9; discussion 229. PubMed ID: 16444162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]